355412 <common-name>(1r)-3,5,5-trimethyl-4-[(3e,5e,7e,9e,11e,13e,15e,17e)-3,7,12,16-tetramethyl-18-(2,3,4-trimethylphenyl)octadeca-3,5,7,9,11,13,15,17-octaen-1-ynyl]cyclohex-3-en-1-ol</common-name> <description>(1r)-3,5,5-trimethyl-4-[(3e,5e,7e,9e,11e,13e,15e,17e)-3,7,12,16-tetramethyl-18-(2,3,4-trimethylphenyl)octadeca-3,5,7,9,11,13,15,17-octaen-1-ynyl]cyclohex-3-en-1-ol is a chemical compound with the formula C40H50O. With an average molecular weight of 546.80 g/mol, (1r)-3,5,5-trimethyl-4-[(3e,5e,7e,9e,11e,13e,15e,17e)-3,7,12,16-tetramethyl-18-(2,3,4-trimethylphenyl)octadeca-3,5,7,9,11,13,15,17-octaen-1-ynyl]cyclohex-3-en-1-ol is a heavy molecule.</description> <cas nil="true"/> <pubchem-id>163024528</pubchem-id> <chemical-formula>C40H50O</chemical-formula> <weight>546.8</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T23:55:21Z</created-at> <updated-at type="dateTime">2026-08-31T23:55:21Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CC1=C(C(CC(C1)O)(C)C)C#CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=CC2=C(C(=C(C=C2)C)C)C)C)C</moldb-smiles> <moldb-formula>C40H50O</moldb-formula> <moldb-inchi>InChI=1S/C40H50O/c1-29(17-13-19-31(3)21-24-37-25-23-33(5)35(7)36(37)8)15-11-12-16-30(2)18-14-20-32(4)22-26-39-34(6)27-38(41)28-40(39,9)10/h11-21,23-25,38,41H,27-28H2,1-10H3/b12-11+,17-13+,18-14+,24-21+,29-15+,30-16+,31-19+,32-20+/t38-/m1/s1</moldb-inchi> <moldb-inchikey>SIBBLZCWSMCOKD-YMGIVJASSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">546.3861662</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>12.2</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM351305</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>(1r)-3,5,5-trimethyl-4-[(3e,5e,7e,9e,11e,13e,15e,17e)-3,7,12,16-tetramethyl-18-(2,3,4-trimethylphenyl)octadeca-3,5,7,9,11,13,15,17-octaen-1-ynyl]cyclohex-3-en-1-ol</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Lipids and lipid-like molecules</superklass> <klass>Prenol lipids</klass> <subklass>Diterpenoids</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0305664</sync-id> <structure-inchikey>SIBBLZCWSMCOKD-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>1000001000000000000000000000000000004000000000000010000080000000000000000010000000000000000000000000280000000008000000000000000080000000000020000000100000000000821000200000000000000000000000008010000001000000000000000000000020000004040000000000000500000000048000000004000000000004000000000000000000000000000400020008000000100000000000000080100000000000000000000000000000010004000000000008000000022002000000000080000140004002000020200000040000000000000000000000040000000001000004000040000000000000000008000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAApAAAAKgAAAIABBgBgAAAAAQMGACgAAAAD BAYAKAAAAAMEBgAgAAAABAYAYAAAAAICBgBgAAAAAwEGAGAAAAACAggAYAAA AAEBBgBgAAAAAQMGAGAAAAABAwYAKAAAAAIEBgAoAAAAAgQGACgAAAADBAYA aAAAAAMDAQYAaAAAAAMDAQYAaAAAAAMDAQYAKAAAAAMEBgBoAAAAAwMBBgBo AAAAAwMBBgBoAAAAAwMBBgBoAAAAAwMBBgAoAAAAAwQGAGAAAAABAwYAaAAA AAMDAQYAaAAAAAMDAQYAaAAAAAMDAQYAKAAAAAMEBgBgAAAAAQMGAGgAAAAD AwEGAGgAAAADAwEGQCgAAAADBAZAKAAAAAMEBkAoAAAAAwQGQCgAAAADBAZA aAAAAAMDAQZAaAAAAAMDAQYAYAAAAAEDBgBgAAAAAQMGAGAAAAABAwYAYAAA AAEDBgBgAAAAAQMLAAEAAQIoAgIDAAMEAAQFAAUGAAUHAAMIAAMJAAIKIAoL KAMLDCAMDSgCDQ4gDg8oAg8QIBARKAIREiASEygCExQgFBUoAhUWABUXIBcY KAIYGSAZGigCGhsAGhwgHB0oAh0eIB4faAwfIGgMICFoDCEiaAwiI2gMISQA ICUAHyYAECcADCgABgEAIx5oDEICAAAABgEGBQQDAgYfICEiIx4XBAAAAAAA AAAW </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:53:19Z</structure-indexed-at> </compound>